These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2435061)

  • 1. The fusion glycoprotein of Sendai virus: sequence analysis of an epitope involved in fusion and virus neutralization.
    Portner A; Scroggs RA; Naeve CW
    Virology; 1987 Apr; 157(2):556-9. PubMed ID: 2435061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of amino acids recognized by syncytium-inhibiting and neutralizing monoclonal antibodies to the human parainfluenza type 3 virus fusion protein.
    Coelingh KV; Tierney EL
    J Virol; 1989 Sep; 63(9):3755-60. PubMed ID: 2474672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein.
    van Wyke Coelingh K; Tierney EL
    J Virol; 1989 Jan; 63(1):375-82. PubMed ID: 2462062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single amino acid substitution of Sendai virus at the cleavage site of the fusion protein confers trypsin resistance.
    Itoh M; Shibuta H; Homma M
    J Gen Virol; 1987 Nov; 68 ( Pt 11)():2939-44. PubMed ID: 2824671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations located on both F1 and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies.
    Neyt C; Geliebter J; Slaoui M; Morales D; Meulemans G; Burny A
    J Virol; 1989 Feb; 63(2):952-4. PubMed ID: 2463386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.
    Arbiza J; Taylor G; López JA; Furze J; Wyld S; Whyte P; Stott EJ; Wertz G; Sullender W; Trudel M
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2225-34. PubMed ID: 1383404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of functional sites on the hemagglutinin-neuraminidase glycoprotein of Sendai virus by sequence analysis of antigenic and temperature-sensitive mutants.
    Thompson SD; Portner A
    Virology; 1987 Sep; 160(1):1-8. PubMed ID: 2820122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumotropic revertants derived from a pantropic mutant, F1-R, of Sendai virus.
    Tashiro M; James I; Karri S; Wahn K; Tobita K; Klenk HD; Rott R; Seto JT
    Virology; 1991 Sep; 184(1):227-34. PubMed ID: 1651590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus fusion glycoprotein: further characterization of a major epitope involved in virus neutralization.
    Trudel M; Nadon F; Séguin C; Payment P; Talbot PJ
    Can J Microbiol; 1987 Oct; 33(10):933-8. PubMed ID: 2446731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Location of neutralizing epitopes on the fusion protein of Newcastle disease virus strain Beaudette C.
    Yusoff K; Nesbit M; McCartney H; Meulemans G; Alexander DJ; Collins MS; Emmerson PT; Samson AC
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():3105-9. PubMed ID: 2479718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease activation mutants of Sendai virus: sequence analysis of the mRNA of the fusion protein (F) gene and direct identification of the cleavage-activation site.
    Hsu MC; Scheid A; Choppin PW
    Virology; 1987 Jan; 156(1):84-90. PubMed ID: 3027971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function.
    Beeler JA; van Wyke Coelingh K
    J Virol; 1989 Jul; 63(7):2941-50. PubMed ID: 2470922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct functions of antigenic sites of the HN glycoprotein of Sendai virus.
    Portner A; Scroggs RA; Metzger DW
    Virology; 1987 May; 158(1):61-8. PubMed ID: 2437698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus.
    Bourgeois C; Corvaisier C; Bour JB; Kohli E; Pothier P
    J Gen Virol; 1991 May; 72 ( Pt 5)():1051-8. PubMed ID: 2033389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separate epitopes in the envelope of visna virus are responsible for fusion and neutralization: biological implications for anti-fusion antibodies in limiting virus replication.
    Crane SE; Clements JE; Narayan O
    J Virol; 1988 Aug; 62(8):2680-5. PubMed ID: 2455817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide sequence of the gene encoding the fusion glycoprotein of Newcastle disease virus.
    Chambers P; Millar NS; Emmerson PT
    J Gen Virol; 1986 Dec; 67 ( Pt 12)():2685-94. PubMed ID: 3025345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Sendai virus mRNAs with cDNA clones of viral genes and sequences of biologically important regions of the fusion protein.
    Hsu M; Choppin PW
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7732-6. PubMed ID: 6096854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein.
    Crowe JE; Firestone CY; Crim R; Beeler JA; Coelingh KL; Barbas CF; Burton DR; Chanock RM; Murphy BR
    Virology; 1998 Dec; 252(2):373-5. PubMed ID: 9878616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the putative HR-C region of the measles virus F2 glycoprotein modulate syncytium formation.
    Plemper RK; Compans RW
    J Virol; 2003 Apr; 77(7):4181-90. PubMed ID: 12634376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection.
    Palomo C; Mas V; Detalle L; Depla E; Cano O; Vázquez M; Stortelers C; Melero JA
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6498-6509. PubMed ID: 27550346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.